Gemini Therapeutics (GMTX) Stock Chart & Stock Price History → On June 10, Nvidia makes its next big move (From Weiss Ratings) (Ad) Free GMTX Stock Alerts $33.95 -0.68 (-1.96%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrends Gemini Therapeutics Stock Price Performance5 Day Performance-0.96%1 Month Performance+19.00%3 Month Performance-50.56%6 Month Performance-38.47%Year-To-Date Performance-41.22%1 Year Performance-8.56% Receive GMTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsOn June 10, Nvidia makes its next big moveA small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. GMTX Stock Chart for Saturday, June, 1, 2024 GMTX Chart by TradingView Gemini Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$34.63$33.95-1.96%$34.87$33.29353,862 shs$1.47 billion05/30/2024$34.66$34.63-0.09%$35.42$33.78257,200 shs$1.50 billion05/29/2024$34.28$34.66+1.11%$36.38$33.56604,950 shs$1.50 billion05/28/2024$34.28$34.28$34.92$31.60565,684 shs$1.49 billion05/27/2024$34.28$34.28$34.92$31.60565,684 shs$1.49 billion05/24/2024$33.17$33.35+0.54%$33.67$32.46408,187 shs$1.44 billion Get the Latest News and Ratings for GMTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$31.26$33.17+6.11%$33.51$31.03309,533 shs$1.44 billion05/22/2024$32.37$31.26-3.43%$32.23$30.65401,749 shs$1.35 billion05/21/2024$32.18$32.37+0.59%$32.41$30.96200,645 shs$1.40 billion05/20/2024$32.18$32.18$32.48$31.44376,433 shs$1.39 billion05/17/2024$31.86$31.92+0.19%$32.25$31.10228,793 shs$1.38 billion05/16/2024$31.84$31.86+0.06%$33.17$31.56389,231 shs$1.38 billion05/15/2024$31.01$31.84+2.68%$32.31$30.97393,596 shs$1.38 billion05/14/2024$31.01$31.01$32.34$30.79241,334 shs$1.34 billion05/13/2024$30.36$31.01+2.14%$32.34$30.79241,266 shs$1.34 billion05/10/2024$30.77$30.77$31.36$28.25344,682 shs$1.33 billion05/09/2024$29.34$30.77+4.87%$31.36$28.25344,663 shs$1.33 billion05/08/2024$30.04$29.34-2.33%$29.88$28.42275,468 shs$1.27 billion05/07/2024$13.50$30.04+122.52%$30.43$29.42311,351 shs$1.30 billion05/06/2024$29.79$13.50-54.68%$14.10$13.506,380 shs$584.93 million05/03/2024$29.00$29.00$29.77$28.40276,190 shs$1.26 billion05/02/2024$28.53$29.00+1.65%$29.77$28.40276,189 shs$1.26 billion05/01/2024$28.29$28.53+0.85%$29.71$27.79437,334 shs$1.24 billion04/30/2024$28.29$28.29$28.67$27.39227,276 shs$1.23 billion04/29/2024$27.55$28.29+2.69%$28.67$27.39227,271 shs$1.23 billion04/26/2024$26.52$27.55+3.88%$27.90$25.64368,874 shs$1.19 billion04/25/2024$27.00$26.52-1.78%$27.04$25.86314,532 shs$1.15 billion04/24/2024$27.00$27.00$28.53$26.98554,062 shs$1.17 billion04/23/2024$28.69$27.00-5.89%$28.53$26.98554,061 shs$1.17 billion04/22/2024$28.69$28.69$30.06$28.08565,171 shs$1.24 billion04/19/2024$30.02$30.02$30.38$29.85315,938 shs$1.30 billion04/18/2024$30.28$30.02-0.86%$30.38$29.85315,937 shs$1.30 billion04/17/2024$30.52$30.28-0.79%$30.47$29.31334,232 shs$1.31 billion04/16/2024$31.83$30.52-4.12%$32.55$30.39387,341 shs$1.32 billion04/15/2024$31.83$31.83$32.49$31.54408,305 shs$1.38 billion04/12/2024$31.52$32.04+1.65%$32.46$30.96426,082 shs$1.39 billion04/11/2024$32.08$31.52-1.75%$31.97$30.40479,392 shs$1.37 billion04/10/2024$31.78$32.08+0.94%$32.89$31.14466,665 shs$1.39 billion04/09/2024$30.10$31.78+5.58%$31.92$29.90504,478 shs$1.38 billion04/08/2024$30.10$30.10$31.15$28.75583,687 shs$1.30 billionOn June 10, Nvidia makes its next big move (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are.04/05/2024$29.50$30.10+2.03%$31.15$28.75583,687 shs$1.30 billion04/04/2024$32.04$29.50-7.91%$31.86$29.34896,485 shs$1.28 billion04/03/2024$34.21$32.04-6.36%$33.00$29.361.48 million shs$1.39 billion04/02/2024$34.21$34.21$35.40$25.606.15 million shs$1.48 billion04/01/2024$62.26$34.21-45.05%$35.40$25.606.15 million shs$1.48 billion03/29/2024$62.26$62.26$62.69$59.20263,991 shs$2.70 billion03/28/2024$60.30$62.26+3.25%$62.69$59.20263,991 shs$2.70 billion03/27/2024$60.30$60.30$60.61$59.00248,993 shs$2.61 billion03/26/2024$59.50$60.30+1.34%$60.61$59.00248,992 shs$2.61 billion03/25/2024$60.61$59.50-1.83%$60.96$58.91251,720 shs$2.58 billion03/22/2024$66.40$61.41-7.52%$68.86$59.54601,133 shs$2.66 billion03/21/2024$67.64$66.40-1.83%$67.80$63.82261,566 shs$2.88 billion03/20/2024$66.04$67.64+2.42%$67.76$65.18194,684 shs$2.93 billion03/19/2024$66.04$66.04$66.43$60.74356,907 shs$2.86 billion03/18/2024$61.78$66.04+6.90%$66.43$60.74348,296 shs$2.86 billion03/15/2024$65.46$63.03-3.71%$65.59$61.65206,347 shs$2.73 billion03/14/2024$65.46$65.46$66.32$63.48233,715 shs$2.84 billion03/13/2024$64.42$65.46+1.61%$66.32$63.48233,715 shs$2.84 billion03/12/2024$65.29$64.42-1.33%$65.69$60.98485,277 shs$2.79 billion03/11/2024$65.29$65.29$66.78$62.76281,430 shs$2.83 billion03/08/2024$66.08$65.29-1.20%$66.78$62.76281,387 shs$2.83 billion03/07/2024$69.04$66.08-4.29%$70.54$64.97309,736 shs$2.86 billion03/06/2024$69.04$69.04$73.66$68.00358,843 shs$2.99 billion03/05/2024$75.32$69.04-8.34%$73.66$68.00353,937 shs$2.99 billion03/04/2024$75.32$75.32$75.52$68.55379,169 shs$3.26 billion03/01/2024$68.67$68.67$69.38$66.54409,609 shs$2.98 billion02/29/2024$65.14$68.67+5.42%$69.38$66.54409,603 shs$2.98 billion Related Companies: Organon & Co. Stock Price Chart Ionis Pharmaceuticals Stock Price Chart BridgeBio Pharma Stock Price Chart Cytokinetics Stock Price Chart Madrigal Pharmaceuticals Stock Price Chart Apellis Pharmaceuticals Stock Price Chart Alpine Immune Sciences Stock Price Chart Nuvalent Stock Price Chart Alkermes Stock Price Chart Perrigo Stock Price Chart Receive GMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GMTX) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport Society“This will be one of the biggest revolutions ever.” - NVIDIA CEOBehind the MarketsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gemini Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.